Type III allergies: identifying and treating delayed food allergies

Can you tolerate these foods? More and more people can’t due to food allergies. On the occasion of Food Allergy Day, we reported last week on type I allergies. Today, we will devote our [...]

Adalimumab monitoring improves therapy success

The drug adalimumab is used very successfully in the treatment of various inflammatory diseases. Yet in some patients, the efficacy of this drug decreases over time. We explain why this is so and [...]

Tick season is here: Diagnosis of TBE/FSME made easy

Tick season has started and the risk of dangerous infections with TBE/FSME is increasing. In the event of a suspected infection and to clarify immunization, antibody detection is the method of choice.

Colon cancer awareness month: Early detection can save lives

As every year, March is officially “Colon Cancer Awareness Month”. A great opportunity to highlight the importance of screening. Nowadays, modern tests have made the early detection of [...]

Detection of legionella with RIDASCREEN® Legionella

The new assay RIDASCREEN ® Legionella of R-Biopharm closes the gap in test portfolio for the detection of life-threatening infectious diseases.

Diabetes mellitus and pancreatic insufficiency

Almost 50 % of type one diabetics and about 33 % of type 2 diabetics will develop a pancreatic insufficiency in the course of their disease.

Differentiation of IBD and IBS with Calprotectin in Stool

It is often difficult to differentiate patients with inflammatory bowel disease (IBD) those who suffer from irritable bowel syndrome due to similar symptoms of patients. Both groups show similar [...]

Colon cancer prevention with immunological stool tests

According to the Robert Koch Institute (RKI) every year 63.000 people in Germany fall ill with colon cancer. Approximately 25,000 people die annually from the consequences of this disease. Colon [...]

TNFalpha Blocker and Drug Monitoring

TNFalpha blocker are biologic agents, which are used for the treatment of inflammatory diseases such as Ulcerative Colitis, Crohns disease and Rheumatoid Arthritis. Infliximab (Remicade®, [...]

Calprotectin predicts relaps after stopping TNFα treatment

Molander et al. investigated if concentrations of fecal calprotectin can be used for predicting relaps after stopping TNFα blocking therapy in patients with Ulcerative Colitis and Morbus Crohn.